Annonce

Log ud Log ind
Log ud Log ind
Ledelse

FDA offentliggør hemmelig 42-siders Pfizer rapport: 160.000 tilfælde med bivirkninger af vaccine allerede i februar

Morten W. Langer

torsdag 23. december 2021 kl. 16:26

Uddrag fra Zerohedge:

As the FDA prepares to approve Pfizer’s new pill for treating high-risk patients infected with COVID, more information about dangerous side effects tied to its vaccine are coming to light.

Just yesterday, we reported another death tied to the vaccine in New Zealand. Now, documents released by the FDA reveal that drugmaker Pfizer recorded nearly 160K adverse reactions to its COVID vaccine in the initial months of its rollout.

The data were obtained by a group of doctors, professors, and journalists calling themselves Public Health and Medical Professionals for Transparency. They filed a Freedom of Information Act request with the FDA asking for their release. And the first tranche of documents revealed that, as of February 2021, when Pfizer’s shot was being rolled out worldwide on an emergency basis, the drugmaker had compiled more than 42K case reports detailing nearly 160K individual adverse reactions to the vaccine.

The data show the bulk of the adverse event cases, both serious and non-serious, were classified as “general disorders”.

Among the more common conditions reported were fevers (pyrexia), fatigue, and diarrhea, among others.

But perhaps the most surprising number in the entire report is that more than 1K of these cases were fatal in the US. All told, more than 3K deaths have been linked to the vaccine, something that’s in line with the company’s own data. Critics have argued that some of the deaths can’t be conclusively linked to the vaccine, but others have instead insisted that the number of deaths might still be underreported.

Keep in mind, these data were used by the FDA to declare the Pfizer jab safe, which it did for Americans aged 16 and older in August. It has since been approved for children as young as five, along with booster doses for people aged 16 and up as of last week.

Readers can find the complete breakdown of data from Public Health and Medical Professionals For Transparency below:

5.3.6 Postmarketing Experience on Scribd

277,096
Tilmeld dig vores gratis nyhedsbrev
ØU Bestyrelsesguiden

Få de vigtigste nyheder om praktisk bestyrelsesarbejde, ledelse og strategi i SMV.
Udkommer hver onsdag.

Jeg giver samtykke til, at I sender mig mails med de seneste historier fra Økonomisk Ugebrev. Lejlighedsvis må I gerne sende mig gode tilbud og information om events. Samtidig accepterer jeg ØU’s Privatlivspolitik.

Du kan til enhver tid afmelde dig med et enkelt klik.

[postviewcount]

Jobannoncer

No data was found

Mere fra ØU Ledelse

Log ind

Har du ikke allerede en bruger? Opret dig her.

*Tilbuddet gælder ikke, hvis man har været abonnent indenfor de seneste 6 måneder

Tilmeld dig vores nyhedsbrev

Og modtag ØU’s rapport om Top 40 Ledelseskonsulenter gratis.

FÅ VORES STORE NYTÅRSUDGAVE AF FORMUE

Her er de 10 bedste aktier i 2022

Tilbuddet udløber om:
dage
timer
min.
sek.

Analyse af og prognoser for Fixed Income (statsrenter og realkreditrenter)

Direkte adgang til opdaterede analyser fra toneangivende finanshuse:

Goldman Sachs

Fidelity

Danske Bank

Morgan Stanley

ABN Amro

Jyske Bank

UBS

SEB

Natixis

Handelsbanken

Merril Lynch 

Direkte adgang til realkreditinstitutternes renteprognoser:

Nykredit

Realkredit Danmark

Nordea

Analyse og prognoser for kort rente, samt for centralbankernes politikker

Links:

RBC

Capital Economics

Yardeni – Central Bank Balance Sheet 

Investing.com: FED Watch Monitor Tool

Nordea

Scotiabank